Holen Sie sich die Stockscreener-App
0.46
4.03%
0.0178
Handel nachbörslich:
.47
0.010
+2.17%
Schlusskurs vom Vortag:
$0.4422
Offen:
$0.4477
24-Stunden-Volumen:
200.15K
Relative Volume:
1.01
Marktkapitalisierung:
$7.86M
Einnahmen:
$4.03M
Nettoeinkommen (Verlust:
$24.32M
KGV:
-0.107
EPS:
-4.3008
Netto-Cashflow:
$-45.76M
1W Leistung:
-0.90%
1M Leistung:
-22.99%
6M Leistung:
-30.20%
1J Leistung:
-37.84%
1-Tages-Spanne:
$0.44
$0.4717
1-Wochen-Bereich:
$0.304
$0.48
52-Wochen-Spanne:
$0.304
$1.90
Pavmed Inc Stock (PAVM) Company Profile
Firmenname
Pavmed Inc
Sektor
Branche
Telefon
(212) 949-4319
Adresse
360 MADISON AVENUE, NEW YORK, NY
Vergleichen Sie PAVM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
0.46 | 7.65M | 4.03M | 24.32M | -45.76M | -4.3008 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-03-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-05 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2018-06-28 | Eingeleitet | Maxim Group | Buy |
Pavmed Inc Aktie (PAVM) Neueste Nachrichten
PAVmed's Q2 2025 Earnings Call: Unraveling Contradictions in Medicare Strategy, FDA Timelines, and Biopharma Expansion - AInvest
Transcript : PAVmed Inc., Lucid Diagnostics Inc., Q2 2025 Earnings Call, Aug 13, 2025 - MarketScreener
Earnings call transcript: Lucid Diagnostics highlights Q2 2025 growth and Medicare focus - Investing.com India
Lucid Diagnostics Inc: Navigating Earnings Challenges and Strategic Growth in a Competitive Diagnostics Landscape - AInvest
Lucid Diagnostics Advances Towards Medicare Coverage - TipRanks
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results - PR Newswire
What makes PAVmed Inc. stock price move sharplyShort-Term Explosive Growth - thegnnews.com
PAVmed's Q2 2025 Earnings: A Strategic Inflection Point in Healthcare Innovation and Financial Turnaround - AInvest
PAVmed PAVM 2025Q2 Earnings Preview Upside Potential Driven by Strategic Innovations - AInvest
Lucid Diagnostics to Participate in Upcoming Investor Conferences - Eastern Progress
Published on: 2025-08-05 15:46:56 - metal.it
Trendline Breach Raises Concern for PAVmed Inc. InvestorsTriple Return Setup With Risk Control Explained - metal.it
PAVmed Inc. Forms Bullish Flag — Upside AheadEntry Plan for Oversold Reversal Stocks Released - metal.it
PAVmed Inc. Crosses 200 Day MA — Signal or NoiseReal-Time Analysis With Entry Targets In Progress - metal.it
Is PAVmed Inc. a growth stock or a value stockHigh-velocity gains - Jammu Links News
What are analysts’ price targets for PAVmed Inc. in the next 12 monthsUnlock exclusive stock analysis for investors - Jammu Links News
What analysts say about PAVmed Inc. stockUnlock powerful trading alerts for success - Jammu Links News
What are the latest earnings results for PAVmed Inc.Free Stock Selection - Jammu Links News
Does PAVmed Inc. stock perform well during market downturnsTrack high-yield stocks before they peak - Jammu Links News
When is PAVmed Inc. stock expected to show significant growthTremendous portfolio expansion - Jammu Links News
How strong is PAVmed Inc. company’s balance sheetCapitalize on emerging market sectors - Jammu Links News
What markets is BHST expanding into Is PAVmed Inc. stock a good long term investment option - Jammu Links News
Nasdaq Grants PAVmed 180-Day Extension to Meet Minimum Bid Price Rule - AInvest
Pavmed Inc. shares fall 1.22% after-hours following announcement of a business update conference call. - AInvest
PAVmed gets 180-day extension to regain Nasdaq listing compliance - MSN
PAVmed to Host Business Update Conference Call on August 14, 2025. - AInvest
PAVmed CEO and CFO to Present Q2 2025 Results and Growth Strategy Update on August 14 - Stock Titan
Pattern recognition hints at PAVmed Inc. upsideCommunity Shared Smart Money Signals Show Movement - metal.it
Lucid Diagnostics to Host Business Update Conference Call and Webcast on August 13, 2025 - AInvest
Should I hold or sell PAVmed Inc. stock in 2025Advanced Screener Ideas For Fast Growth - Jammu Links News
Why PAVmed Inc. stock attracts strong analyst attentionGrowth Based Investment Plan Guidance Highlighted - beatles.ru
Real Time Chart Alerts Flash Bullish on PAVmed Inc.Optimized Watchlist With Daily Adjustments Launched - beatles.ru
PAVmed granted 180-day extension to meet Nasdaq minimum bid price - Investing.com Nigeria
PAVmed Granted Nasdaq Extension for Compliance - TipRanks
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 - WV News
PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PR Newswire
PAVmed granted 180-day extension by Nasdaq to regain compliance with minimum bid price rule - MarketScreener
Published on: 2025-07-29 22:46:56 - metal.it
RSI Reset May Fuel Rebound in PAVmed Inc.AI Powered High Return Stock Calls Dominate Watchlists - metal.it
How did PAVM's revenue and expenses trend in Q4 2024? - AInvest
What is the dividend policy of PAVmed Inc. stockSmart Portfolio Signals To Watch Now - Jammu Links News
Finanzdaten der Pavmed Inc-Aktie (PAVM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):